Michael Falster
0000-0001-6444-7272
University of New South Wales
1 paper found
Refreshing results…
Estimated Lifetime Cardiovascular, Kidney and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Non-steroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria
Missing publications? Search for publications with a matching author name.